Nanomedicine News

RSS
BioAlliance Pharma Starts Clinical Batches Production of its Nanoparticle Transdrug Technology

BioAlliance Pharma Starts Clinical Batches Production of its Nanoparticle Transdrug Technology

Nanovircides Plans to Use its Optimization Technology to Enhance its HIVCide Candidate

Nanovircides Plans to Use its Optimization Technology to Enhance its HIVCide Candidate

New Book on Lipid Nanocarriers in Cancer Diagnosis and Therapy

New Book on Lipid Nanocarriers in Cancer Diagnosis and Therapy

Shasun Pharma Thrust Invests on Nanotech Project for Cancer Treatment

Shasun Pharma Thrust Invests on Nanotech Project for Cancer Treatment

IBN Promises Safer Stem Cell Therapy for Cancer Patients

IBN Promises Safer Stem Cell Therapy for Cancer Patients

MIT Student Develops Innovative 3D Microfluidic Platform for Cancer Therapy

MIT Student Develops Innovative 3D Microfluidic Platform for Cancer Therapy

Researchers Develop Nanotech Device Using Olfactory Receptor Proteins and Carbon Nanotubes

Researchers Develop Nanotech Device Using Olfactory Receptor Proteins and Carbon Nanotubes

NanoViricides’ Anti-HIV Candidate Protects Human T Cells Similar to HAART Therapy

NanoViricides’ Anti-HIV Candidate Protects Human T Cells Similar to HAART Therapy

Alnylam, MIT Develop Core-Shell Nanoparticles for RNAi Therapeutic Delivery Applications

Alnylam, MIT Develop Core-Shell Nanoparticles for RNAi Therapeutic Delivery Applications

Nanotechnology May Solve the Shortcomings of Viagra

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.